http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3ff1a26ec98692ca10896f77115f323
Outgoing Links
Predicate | Object |
---|---|
family-name | Yonemori |
name | Kan Yonemori |
given-name | Kan |
organization-name | Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan Department of Medical Oncology, National Cancer Center Hospital , Chuo-ku, Tokyo , Japan Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan. kyonemor@ncc.go.jp Department of Breast and Medical Oncology, National Cancer Center Hospital, Japan Division of Breast and Medical Oncology National Cancer Center Hospital Tokyo Japan a Biostatistics and Bioinformatics Section, Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan Department of Breast and Medical Oncology National Cancer Center Hospital Tokyo Department of Medical Oncology National Cancer Center Hospital Tsukiji Tokyo Japan Breast and Medical Oncology; Rare Cancer Center, National Cancer Center Hospital Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan. kyonemor@ncc.go.jp. Department of Breast and Medical Oncology National Cancer Center Hospital National Cancer Center Tokyo Japan; Department of Experimental Therapeutics National Cancer Center Hospital National Cancer Center Tokyo Japan; Investigational Drug Branch Cancer Therapy Evaluation Program Division of Cancer Treatment and Diagnosis National Cancer Institute National Institute of Health Rockville Maryland USA National Cancer Center Hospital, Chuo-ku, Tokyo, Japan Department of Medical Oncology National Cancer Center Hospital Tokyo; Rare Cancer Center National Cancer Center Hospital Tokyo Department of Breast and Medical Oncology National Cancer Center Hospital Tokyo Japan; Department of Experimental Therapeutics National Cancer Center Hospital Tokyo Japan; Investigational Drug Branch Cancer Therapy Evaluation Program Division of Cancer Treatment and Diagnosis National Cancer Institute, National Institute of Health Rockville MD USA National Cancer Center Hospital, Mammary Gland and Oncology. Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104‑0045, Japan Rare Cancer Centre National Cancer Centre Hospital Tokyo Japan; Department of Medical Oncology National Cancer Centre Hospital Tokyo Japan Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan Department of International Clinical Development, National Cancer Center Hospital , Tokyo , Japan; Department of Medical Oncology, National Cancer Center Hospital , Tokyo , Japan International Medical Center of Japan, Tokyo 162-8655, Japan. kyonemor@ncc.go.jp Department of Experimental Therapeutics National Cancer Center Hospital Tokyo Japan National Cancer Center Hospital Department of Medical Oncology, , Chuo-ku, Tokyo , Japan Medical Oncology National Cancer Center Hospital, Chuo‐ku Tokyo Japan Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan Department of Musculoskeletal Oncology National Cancer Center Hospital Tokyo Japan National Cancer Center Hospital, Tokyo, Japan Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan Department of Medical Oncology, National Cancer Center Hospital , Tokyo , Japan Department of Breast and Medical Oncology National Cancer Center Hospital Tokyo Japan Department of Breast and Medical Oncology National Cancer Center Hospital 5‐1‐1 Tsukiji Chuo‐ku Tokyo 1040045 Japan National Cancer Center Hospital Tokyo Japan Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan National Cancer Center Hospital Department of Medical Oncology, , Tokyo, Japan Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan Department of Genome Biology, Kinki University School of Medicine, Osaka, Japan, Medical Oncology, National Cancer Center Hospital, Tokyo, Japan, First Department of Internal Medicine, Osaka Medical College, Osaka, Japan, Shien Lab, National Cancer Center Hospital, Tokyo, Japan, and Department of Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan Divisions of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan Department of Breast and Medical Oncology National Cancer Center Hospital Chuo‐ku Tokyo Japan Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan Medical Oncology; Rare Cancer Center, National Cancer Center Hospital, Tokyo, Japan Department of Breast and Medical Oncology National Cancer Center Hospital, National Cancer Center Tokyo Japan; Office for Advanced Medical Care Evaluation National Cancer Center Tokyo Japan; Investigational Drug Branch Cancer Therapy Evaluation Program Division of Cancer Treatment and Diagnosis National Cancer Institute National Institute of Health Rockville Maryland USA 1Division of Hepatobiliary and Pancreatic Oncology and Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan Medical Oncology, National Cancer Center Hospital; Rare Cancer Center, National Cancer Center Hospital Department of Breast and Medical Oncology Rare Cancer Center National Cancer Center Hospital Tokyo Japan From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and... |
Incoming Links
Total number of triples: 271.